We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Choice Hotels on Expansion Spree, to Develop Mid-Scale Hotels
Read MoreHide Full Article
Choice Hotels International, Inc. (CHH - Free Report) , which banks on solid brand presence and continual expansion for growth, has signed an agreement with Equinox Hospitality to develop mid-scale hotels.
Per the terms of the agreement, three dual-brand Sleep Inn and MainStay Suites properties as well as two stand-alone Sleep Inn hotels will be developed in the Phoenix metropolitan area and California. The company is set to launch its first hotel in 2021. Markedly, Choice Hotels is quite confident about the success of these two brands. Further, the company stated that its domestic pipelines include approximately 300 hotels across the two brands.
This latest move underscores the company’s efforts to expand its footprint and strengthen the midscale category. Driven by its expansion strategy, shares of Choice Hotels have gained nearly 30% in the past two years compared with the S&P 500 increase of 17%.
Strategic Expansion to Drive Growth
Choice Hotels riveting growth potential is backed by the continual expansion of brands. Moreover, its portfolio of well-segmented brands is getting evidently stronger. With continuous enhancement of the mid-scale brand and the acquisition of the WoodSpring brand as well as transformation and advancement of the Comfort and Cambria brands, Choice Hotels is poised for growth in 2019.
In domestic and international markets, Choice Hotels relies heavily on expansion. In the fourth quarter, this hotelier awarded 73 total franchise agreements, out of which 43 were domestic and 30 were international. Alongside domestic growth, the company continues to expand its international footprint in new countries. Key international operating markets include Spain, Colombia, Panama, the Caribbean and Canada.
The company had strengthened its mid-scale presence with the launch of Clarion Pointe. Expansion of the brand is expected to take place through 21 Clarion Pointe franchise agreements.
Choice Hotels, which shares space with Extended Stay America, Inc. , has a Zacks Rank #3 (Hold).
Belmond reported better-than-expected earnings in the trailing two quarters.
Hilton Worldwide Holdings’ long-term earnings are likely to witness 9.1% growth.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Choice Hotels on Expansion Spree, to Develop Mid-Scale Hotels
Choice Hotels International, Inc. (CHH - Free Report) , which banks on solid brand presence and continual expansion for growth, has signed an agreement with Equinox Hospitality to develop mid-scale hotels.
Per the terms of the agreement, three dual-brand Sleep Inn and MainStay Suites properties as well as two stand-alone Sleep Inn hotels will be developed in the Phoenix metropolitan area and California. The company is set to launch its first hotel in 2021. Markedly, Choice Hotels is quite confident about the success of these two brands. Further, the company stated that its domestic pipelines include approximately 300 hotels across the two brands.
This latest move underscores the company’s efforts to expand its footprint and strengthen the midscale category. Driven by its expansion strategy, shares of Choice Hotels have gained nearly 30% in the past two years compared with the S&P 500 increase of 17%.
Strategic Expansion to Drive Growth
Choice Hotels riveting growth potential is backed by the continual expansion of brands. Moreover, its portfolio of well-segmented brands is getting evidently stronger. With continuous enhancement of the mid-scale brand and the acquisition of the WoodSpring brand as well as transformation and advancement of the Comfort and Cambria brands, Choice Hotels is poised for growth in 2019.
In domestic and international markets, Choice Hotels relies heavily on expansion. In the fourth quarter, this hotelier awarded 73 total franchise agreements, out of which 43 were domestic and 30 were international. Alongside domestic growth, the company continues to expand its international footprint in new countries. Key international operating markets include Spain, Colombia, Panama, the Caribbean and Canada.
The company had strengthened its mid-scale presence with the launch of Clarion Pointe. Expansion of the brand is expected to take place through 21 Clarion Pointe franchise agreements.
Choice Hotels, which shares space with Extended Stay America, Inc. , has a Zacks Rank #3 (Hold).
Key Picks
Better-ranked stocks worth considering in the same space include, Belmond Ltd. and Hilton Worldwide Holdings Inc. (HLT - Free Report) . Belmond and Hilton Worldwide Holdings carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Belmond reported better-than-expected earnings in the trailing two quarters.
Hilton Worldwide Holdings’ long-term earnings are likely to witness 9.1% growth.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>